Circadian Acidity Pattern in Prepyloric Ulcers: A Comparison with Normal Subjects and Duodenal Ulcer Patients

References

• Ström M, Gotthard R, Bodemar G, Walan A. Antacid/chol-inergic, cimetidine, and placebo in treatment of active peptic ulcers. Scand J Gastroenterol 1981; 16: 593–602
   PubMed Web of Science ®Google Scholar
• Ippoliti A, Elashoff J, Valenzuela J, et al. Recurrent ulcer after successful treatment with cimetidine or antacid. Gastroenterology 1983; 85: 875–80
   PubMed Web of Science ®Google Scholar
• Lauritsen K, Bytzer P, Hansen J, Bekker C, Rask-Madsen J. Comparison of ranitidine and high-dose antacid in the treatment of prepyloric or duodenal ulcer. A double-blind controlled trial. Scand J Gastroenterol 1985; 20: 123–8
   PubMed Web of Science ®Google Scholar
• Ström M, Berstad A, Bodemar G, Walan A. Results of short-and long-term cimetidine treatment in patients with iuxtapyloric ulcers, with special reference to gastric acid and pepsin secretion. Scand J Gastroenterol 1986; 21: 521–30
   PubMed Web of Science ®Google Scholar
• Andersen D, Amdrup E, Hostrup H, Sorensen F H. The Aarhus county vagotomy trial: trends in the problem of recurrent ulcer after parietal cell vagotomy and selective gastric vagotomy with drainage. World J Surg 1982; 6: 86–92
   PubMed Web of Science ®Google Scholar
• Ström M, Bodemar G, Lindhagen J, Sjodhal R, Walan A. Cimetidine or parietal cell vagotomy in patients with iuxtapyloric ulcers. Lancet 1984; 2: 894–7
   PubMed Web of Science ®Google Scholar
• Baron J H. An assessment of the augmented histamine test in the diagnosis of peptic ulcer. Gut 1963; 4: 243–53
   PubMed Web of Science ®Google Scholar
• Wormsley K G, Grossman M I. Maximal histalog test in control subjects and patients with peptic ulcer. Gut 1965; 6: 427–35
   PubMed Web of Science ®Google Scholar
• Johnson D. Gastric ulcer: classification, blood group characteristics, secretion patterns and pathogenesis. Ann Surg 1965; 162: 996–1004
   PubMed Web of Science ®Google Scholar
• Ornsholt J, Amdrup E, Andersen D, Hostrup H. Aarhus county vagotomy trial. Acid secretory patterns in patients with prepyloric, pyloric and duodenal ulcer. Digestion 1983; 26: 146–50
   PubMed Web of Science ®Google Scholar
• Fimmel C J, Etienne A, Cilluffo T, et al. Long-term ambulatory gastric pH monitoring: validation of a new method and effect of H2 antagonists. Gastroenterology 1985; 88: 1842–51
   PubMed Web of Science ®Google Scholar
• Halter F, Eigenmann F. Is it really more difficult to treat prepyloric ulcers?. Aliment Pharmacol Ther 1987; 1: 433S–8S
   Google Scholar
• Savarino V, Mela G S, Zentilin P, et al. Gastric aspiration versus antimony and glass pH electrodes. A simultaneous comparative in vivo study. Scand J Gastroenterol 1989; 24: 434–9
   PubMed Web of Science ®Google Scholar
• Mela G S, Savarino V, Moretti M, et al. Antimony and glass pH electrodes can be used interchangeably in 24-hour studies on gastric acidity. Dig Dis Sci 1990; 35: 1473–81
   PubMed Web of Science ®Google Scholar
• Savarino V, Mela G S, Scalabrini P, et al. Continuous 24 hour intragastric pH monitoring: focus on reproducibility in duodenal ulcer patients. A preliminary report. Gastroenterol Clin Biol 1986; 10: 826–30
   PubMedGoogle Scholar
• Bauerfeind P, Cilluffo T, Fimmel C J, et al. Does smoking interfere with the effect of histamine H2-receptor antagonists on intragastric acidity in man?. Gut 1987; 28: 549–56
   PubMed Web of Science ®Google Scholar
• Kauffmann D, Wilder-Smith C H, Kempf M, et al. Cigarette smoking, gastric acidity and peptic ulceration. What are the relationships? Dig Dis Sci 1990; 35: 1482–7
   PubMedGoogle Scholar
• Lindell G, Brudin L, Ohlin P, Graffner H. Does smoking influence intragastric acidity?. Eur J Gastroenterol Hepatol 1990; 2: 305–8
   Google Scholar
• Mela G S, Savarino V, Moretti M, Bonifacino G, Sumberaz A, Zentilin P. Clinical relevance of sampling rate in the characterization and analysis of 24-hour gastric acidity. A report on 413 cases. Scand J Gastroenterol 1989; 24: 683–7
   PubMed Web of Science ®Google Scholar
• Mela G S, Savarino V. Continuous long-term gastric pH-metry: further suggestions for optimizing data analysis. Eur J Gastroenterol Hepatol 1990; 2: 318–20
   Google Scholar
• Mela G S, Savarino V, Vigneri S. Optimizing the information obtained from continuous 24-hour gastric pH monitoring. Am J Gastroenterol 1992; 87: 961–6
   PubMedGoogle Scholar
• Walan A, Bader J-P, Classen M, et al. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med 1989; 320: 69–75
   PubMed Web of Science ®Google Scholar
• Gustavsson S, Adami H-O, Löof L, Nyberg A, Nyrén O. Symptomatic cimetidine treatment of duodenal and prepyloric ulcers. Dig Dis Sci 1986; 31: 2–6
   PubMed Web of Science ®Google Scholar
• Brooks F P. The pathophysiology of peptic ulcer disease. Dig Dis Sci 1985; 30(Suppl)15S–29S
   Web of Science ®Google Scholar
• Savarino V, Mela G S, Zentilin P, Celle G. Ulcer heterogeneity: further arguments for a range of antisecretory treatment. Dig Dis Sci 1990; 35: 921–3
   PubMedGoogle Scholar
• Gotthard R, Bodemar G, Tjädermo M, Tobiasson P, Walan A. High gastric bile acid concentration in prepyloric ulcer patients. Scand J Gastroenterol 1985; 20: 429–46
   Google Scholar
• Savarino V, Mela G S, Zentilin P, et al. 24-hour study of gastric acidity in normal subjects and in cholecystectomized patients using continuous pH monitoring. Hepatogastroenterol 1991; 38: 299–301
   PubMedGoogle Scholar
• Hostein J, Bost R, Faure H, Lachet B, Fournet J. Valeur diagnostique de la pH-métrie gastrique au cours du reflux duo-dénogastrique. Gastroenterol Clin Biol 1987; 11: 206–11
   PubMedGoogle Scholar
• Blum A L, Heading R, Muller-Lissner S, Olbe L. Is duo-denogastric reflux clinically relevant?. Gastroenterol Intern 1989; 2: 3–8
   Google Scholar
• McColl K EL, McLauchlan G, Fullarton G M. Comparison of gastric body and antral pH [reply]. Gut 1989; 30: 1435
   PubMedGoogle Scholar
• Muller-Lissner S A, Fimmel C J, Sonnenberg A, et al. Novel approach to quantify duodenogastric reflux in healthy volunteers and in patients with type I gastric ulcer. Gut 1983; 24: 510–8
   PubMed Web of Science ®Google Scholar
• Ormand J E, Talley N J. Helicobacter pylory: controversies and an approach to management. Mayo Clin Proc 1990; 65: 414–26
   PubMed Web of Science ®Google Scholar
• Kang J Y, Wee A. Helicobacter pylori and gastric acid output in peptic ulcer disease. Dig Dis Sci 1991; 36: 5–9
   PubMed Web of Science ®Google Scholar
• Wagner S, Gladziwa U, Haruma K, Varrentrapp M, Gebel M. Effect of Helicobacter pylori infection on 24 hour intragastric acidity in patients with gastritis and duodenal ulcer. Gut 1992; 33: 1024–8
   PubMed Web of Science ®Google Scholar
• Brady C E, III, Hadfield T L, Hyatt J R, Utts S J. Acid secretion and serum gastrin levels in individuals with Campylobacter pylori. Gastroenterology 1988; 94: 923–7
   PubMed Web of Science ®Google Scholar
• Hui W M, Lam S K, Chan P Y, et al. Persistence of Campylobacter pyloridis despite healing of duodenal ulcer and improvement of accompanying duodenitis and gastritis. Dig Dis Sci 1987; 32: 1255–60
   PubMed Web of Science ®Google Scholar